Eletriptan Hydrobromide Tablet, Film Coated
FDA Label NDC 70771-1107

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Eletriptan Hydrobromide (NDC 70771-1107). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Eletriptan hydrobromide Tablets, 20 mg

NDC 70771-1107-3

Rx only

30 Tablets

Eletriptan Hydrobromide Tablet (8cbfff26 Bdf1 425c A96c E32c82c0934f 04)

Eletriptan Hydrobromide Tablet (8cbfff26 Bdf1 425c A96c E32c82c0934f 04)

Eletriptan hydrobromide Tablets, 40 mg

NDC 70771-1108-3

Rx only

30 Tablets

Eletriptan Hydrobromide Tablet (8cbfff26 Bdf1 425c A96c E32c82c0934f 05)

Eletriptan Hydrobromide Tablet (8cbfff26 Bdf1 425c A96c E32c82c0934f 05)

* Please review the disclaimer below.